Danielle Abi‐Saab

1.4k total citations
36 papers, 1.1k citations indexed

About

Danielle Abi‐Saab is a scholar working on Molecular Biology, Psychiatry and Mental health and Pharmacology. According to data from OpenAlex, Danielle Abi‐Saab has authored 36 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Psychiatry and Mental health and 8 papers in Pharmacology. Recurrent topics in Danielle Abi‐Saab's work include Alzheimer's disease research and treatments (7 papers), Tryptophan and brain disorders (7 papers) and Treatment of Major Depression (7 papers). Danielle Abi‐Saab is often cited by papers focused on Alzheimer's disease research and treatments (7 papers), Tryptophan and brain disorders (7 papers) and Treatment of Major Depression (7 papers). Danielle Abi‐Saab collaborates with scholars based in Switzerland, United States and United Kingdom. Danielle Abi‐Saab's co-authors include Anissa Abi‐Dargham, Deepak Cyril D’Souza, Laurence P. Karper, John H. Krystal, John Krystal, Dennis S. Charney, Dennis S. Charney, Malcolm B. Bowers, Paul Delmar and Rachelle S. Doody and has published in prestigious journals such as Neurology, Biological Psychiatry and Neuropsychopharmacology.

In The Last Decade

Danielle Abi‐Saab

35 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Danielle Abi‐Saab Switzerland 13 451 383 302 290 273 36 1.1k
C H van Dyck United States 9 968 2.1× 314 0.8× 207 0.7× 355 1.2× 636 2.3× 12 2.1k
Takashi Futamura Japan 19 517 1.1× 458 1.2× 565 1.9× 131 0.5× 483 1.8× 29 1.6k
Dennis Deptula United States 15 313 0.7× 167 0.4× 125 0.4× 355 1.2× 179 0.7× 28 1.1k
Satoshi Deyama Japan 19 621 1.4× 427 1.1× 510 1.7× 204 0.7× 67 0.2× 57 1.4k
Morozova Ma Russia 13 711 1.6× 170 0.4× 230 0.8× 184 0.6× 628 2.3× 64 1.5k
Chih‐Chia Huang Taiwan 15 241 0.5× 153 0.4× 263 0.9× 130 0.4× 156 0.6× 26 848
Robert Zöchling Germany 9 521 1.2× 203 0.5× 115 0.4× 174 0.6× 158 0.6× 10 1.4k
Radmila Manev United States 19 420 0.9× 174 0.5× 177 0.6× 139 0.5× 105 0.4× 36 1.2k
Samantha L. McLean United Kingdom 15 1.0k 2.3× 210 0.5× 241 0.8× 277 1.0× 297 1.1× 29 1.7k
Shan Xie United States 17 415 0.9× 474 1.2× 173 0.6× 122 0.4× 79 0.3× 26 984

Countries citing papers authored by Danielle Abi‐Saab

Since Specialization
Citations

This map shows the geographic impact of Danielle Abi‐Saab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danielle Abi‐Saab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danielle Abi‐Saab more than expected).

Fields of papers citing papers by Danielle Abi‐Saab

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danielle Abi‐Saab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danielle Abi‐Saab. The network helps show where Danielle Abi‐Saab may publish in the future.

Co-authorship network of co-authors of Danielle Abi‐Saab

This figure shows the co-authorship network connecting the top 25 collaborators of Danielle Abi‐Saab. A scholar is included among the top collaborators of Danielle Abi‐Saab based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danielle Abi‐Saab. Danielle Abi‐Saab is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McDougall, Fiona, Chris J. Edgar, Paul Delmar, et al.. (2021). Psychometric Properties of the Clinical Dementia Rating — Sum of Boxes and other Cognitive and Functional Outcomes in a Prodromal Alzheimer's Disease Population. The Journal of Prevention of Alzheimer s Disease. 8(2). 151–160. 31 indexed citations
2.
Klein, Gregory, Paul Delmar, Geoffrey A. Kerchner, et al.. (2021). Thirty-Six-Month Amyloid Positron Emission Tomography Results Show Continued Reduction in Amyloid Burden with Subcutaneous Gantenerumab. The Journal of Prevention of Alzheimer s Disease. 8(1). 3–6. 44 indexed citations
3.
Klein, Gregory, Luc Bracoud, Derk D. Purcell, et al.. (2020). Calibration of a simplified ARIA‐E MRI severity scale suitable for clinical practice. Alzheimer s & Dementia. 16(S2). 3 indexed citations
4.
5.
Klein, Gregory, Paul Delmar, Nicola Voyle, et al.. (2019). Gantenerumab reduces amyloid-β plaques in patients with prodromal to moderate Alzheimer’s disease: a PET substudy interim analysis. Alzheimer s Research & Therapy. 11(1). 101–101. 158 indexed citations
6.
Klein, Gregory, Paul Delmar, Carsten Hofmann, et al.. (2018). Higher Dose Gantenerumab leads to Significant Reduction in Amyloid Plaque Burden -Results for the Marguerite and Scarlet Road Open Label Extension Studies (S2.005). Neurology. 90(15_supplement). 3 indexed citations
7.
8.
9.
Schooler, Nina R., Robert W. Buchanan, Thomas Laughren, et al.. (2015). Defining therapeutic benefit for people with schizophrenia: Focus on negative symptoms. Schizophrenia Research. 162(1-3). 169–174. 27 indexed citations
10.
Bugarski‐Kirola, Dragana, et al.. (2014). A phase II/III trial of bitopertin monotherapy compared with placebo in patients with an acute exacerbation of schizophrenia – Results from the CandleLyte study. European Neuropsychopharmacology. 24(7). 1024–1036. 73 indexed citations
11.
Blaettler, Thomas, Dragana Bugarski‐Kirola, W. Wolfgang Fleischhacker, et al.. (2014). Efficacy and safety of adjunctive bitopertin (10 and 20mg) versus placebo in subjects with persistent predominant negative symptoms of schizophrenia treated with antipsychotics — Results from the Phase III FlashLyte Study. Schizophrenia Research. 158(1-3). e2–e3. 11 indexed citations
12.
D’Souza, Deepak Cyril, Rajiv Radhakrishnan, Edward Perry, et al.. (2012). Feasibility, Safety, and Efficacy of the Combination of D-Serine and Computerized Cognitive Retraining in Schizophrenia: An International Collaborative Pilot Study. Neuropsychopharmacology. 38(3). 492–503. 64 indexed citations
13.
Abi‐Saab, Danielle, et al.. (2005). The Effect of Alcohol on the Neuropsychological Functioning of Recently Abstinent Cocainedependent Subjects. American Journal on Addictions. 14(2). 166–178. 19 indexed citations
14.
Abi‐Saab, Danielle, Joanna M. Fiszdon, Gary Bryson, & Morris D. Bell. (2005). The implications of memory profiles in schizophrenia on vocational and neuropsychological functioning. Schizophrenia Research. 75(2-3). 173–182. 8 indexed citations
15.
D’Souza, Deepak Cyril, Roberto Gil, Danielle Abi‐Saab, et al.. (2000). IV glycine and oral d-cycloserine effects on plasma and CSF amino acids in healthy humans. Biological Psychiatry. 47(5). 450–462. 87 indexed citations
16.
Krystal, John H., Danielle Abi‐Saab, Ayşenil Belger, et al.. (2000). Dissociation of ketamine effects on rule acquisition and rule implementation: possible relevance to NMDA receptor contributions to executive cognitive functions. Biological Psychiatry. 47(2). 137–143. 149 indexed citations
17.
Krystal, John, Deepak Cyril D’Souza, Laurence P. Karper, et al.. (1999). Interactive effects of subanesthetic ketamine and haloperidol in healthy humans. Psychopharmacology. 145(2). 193–204. 191 indexed citations
18.
Krystal, John, Anissa Abi‐Dargham, Danielle Abi‐Saab, et al.. (1998). Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans. Psychopharmacology. 135(3). 213–229. 147 indexed citations
19.
Krystal, John H., Elizabeth Webb, Anissa Abi‐Dargham, et al.. (1995). Differentiating nmda dysregulation in schizophrenia and alcoholism using ketamine. Schizophrenia Research. 15(1-2). 156–156. 3 indexed citations
20.
D’Souza, Deepak Cyril, et al.. (1994). I.V. glycine/d-cycloserine to facilitate NMDA function in humans. Biological Psychiatry. 35(9). 734–734. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C H van Dyck Breakdown of academic impact, for papers by Takashi Futamura Breakdown of academic impact, for papers by Dennis Deptula Breakdown of academic impact, for papers by Satoshi Deyama Breakdown of academic impact, for papers by Morozova Ma Breakdown of academic impact, for papers by Chih‐Chia Huang Breakdown of academic impact, for papers by Robert Zöchling Breakdown of academic impact, for papers by Radmila Manev Breakdown of academic impact, for papers by Samantha L. McLean Breakdown of academic impact, for papers by Shan Xie
Rankless by CCL
2026